학술논문
Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions.
Document Type
Article
Source
Subject
*SEROTONIN
*RISPERIDONE
*RADIOLIGAND assay
*CHEMICAL affinity
*CHEMICAL inhibitors
*BINDING sites
*BIOLUMINESCENCE
*
*
*
*
*
*
Language
ISSN
0033-3158
Abstract
Rationale: The h5-HT receptor is subject to inactivation by risperidone and 9-OH-risperidone, apparently through a pseudo-irreversible complex formed between these drugs and the receptor. Although risperidone and 9-OH-risperidone ('inactivating antagonists') completely inactivate the receptor, only 50% of the receptors form a pseudo-irreversible complex with these drugs. Objectives: This study aims to more fully determine the mechanism(s) responsible for the novel effects of risperidone and 9-OH-risperidone and to determine if the inactivation can be reversed (reactivation). Methods: The ability of non-inactivating drugs (competitive antagonists) to dissociate wash-resistant [H]risperidone binding from h5-HT receptors was investigated. Also, the ability of non-inactivating drugs to reactivate inactivated h5-HT receptors was investigated, using cAMP accumulation as a functional endpoint. Results: The competitive (non-inactivating) antagonists clozapine and mesulergine released the wash-resistant [H]risperidone binding to the h5-HT receptor. The competitive antagonists clozapine, SB269970, mianserin, cyproheptadine, mesulergine, and ICI169369 reactivated the risperidone-inactivated h5-HT receptors in a concentration-dependent manner. The potencies for reactivation closely match the affinities of these drugs for the h5-HT receptor ( r = 0.95), indicating that the reactivating antagonists are binding to and producing their effects through the orthosteric binding site of the h5-HT receptor. Bioluminescence resonance energy transfer analyses indicate that the h5-HT receptor forms homodimers. Conclusions: The ability of the non-inactivating drugs to bind h5-HT orthosteric sites and reverse the wash-resistant effects of risperidone or 9-OH-risperidone, also bound to h5-HT orthosteric sites, is evidence for protomer-protomer interactions between h5-HT homodimers. This is the first demonstration of a non-mutated G-protein-coupled receptor homodimer engaging in protomer-protomer interactions in an intact cell preparation. [ABSTRACT FROM AUTHOR]